Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

Durable Capital Partners PRVA trades

Henry Ellenbogen

Henry Ellenbogen Privia Health Group Inc stake

total: 158

Trades details

Total transactions:
6
New positions:
1
Added:
4
Reduced:
1
Held since:
2023 Q2
Held for:
13 quarters
Latest activity:
2026 Q2
According to 2026 Q2 report, Henry Ellenbogen holds 11,635,948 Privia Health Group Inc (PRVA) shares with a market value of roughly $299.39M accounting for 2.91% of the overall portfolio. To date, the estimated cost basis is nearly $24.49 for "buy" trades and estimated average "sell" price is $25.73. Durable Capital Partners first purchased PRVA in 2023 Q2, initially acquiring about 9.09M shares. Since the initial investment in Privia Health Group Inc (PRVA), Durable Capital Partners has made 5 more transactions.

How many PRVA shares does Henry Ellenbogen currently hold?

According to 2026 Q2 report, Henry Ellenbogen holds 11,635,948 shares of Privia Health Group Inc (PRVA), valued at around $299.39M.

When did Henry Ellenbogen buy Privia Health Group Inc (PRVA)?

Henry Ellenbogen first invested in Privia Health Group Inc (PRVA) in 2023 Q2 at the reported quarter-end price of $26.11 per share.

What's the cost basis of Durable Capital Partners's PRVA stake?

The estimated cost basis for Privia Health Group Inc (PRVA) stake is around $24.49 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$24.49
Weighted AVG sell price:
$25.73

Henry Ellenbogen's historical trades in Privia Health Group Inc

6 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q2
2.91%
11,635,948
$25.73
$299,392,942
-3.74% (-451,895)
-0.12%
2025 Q4
2.71%
12,087,843
$23.71
$286,602,758
+3.39% (+396,158)
+0.09%
2025 Q3
2.16%
11,691,685
$24.90
$291,122,957
+1.77% (+203,842)
+0.04%
2024 Q4
1.83%
11,487,843
$19.55
$224,587,331
+3.40% (+378,255)
+0.06%
2024 Q3
1.48%
11,109,588
$18.21
$202,305,597
+22.21% (+2,018,679)
+0.27%
2023 Q2
2.08%
9,090,909
$26.11
$237,363,634
new
+2.08%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.